The site is temporarily down due to maintenance. Sorry for the inconvenience.

The site is temporarily down due to maintenance. Sorry for the inconvenience.

Quality & Accuracy

Experience

The latest technologies

Speed ​​&
Credibility

Inhibin A | Laboratory research

Known as: Inhibin A
SKU: 210

132.00

Study material: Venous blood
Response time (working day): 14
The test is done on an empty stomach: Yes
Home call service: Yes
Country: EU

General Information

Inhibins are hormones of the reproductive system that are involved in the development of oocytes (ovum precursor cells). In women, inhibins are produced mainly by the granulosa cells of the ovary, during pregnancy - by the placenta. Their amounts are different in different phases of the ovary. Inhibin A levels are low in the early follicular phase, increase during ovulation, and reach a maximum in the midluteal phase. Inhibin B, on the contrary, is high in the follicular phase and then decreases.

Inhibin selectively inhibits the secretion of FSH by the pituitary gland (based on the principle of negative feedback), regulates folliculogenesis and spermatogenesis, has a local paracrine effect on the gonads. Inhibin synthesis reduces gonadoliberin secretion; Androgens, FSH and insulin-like growth factor-1 increase its secretion.

Inhibin A is used to diagnose and monitor the treatment of ovarian granulosa cell tumors, and sometimes mucinous, epithelial tumors. However, in some of the confirmed cases of these tumors, there is no increase in the amount of inhibin A (or B).

Inhibin levels are high during premenopause, corresponding to the phases of the cycle.

 

In boys, the level of inhibin increases during childhood, the peak of concentration is at 3 months, which is accompanied by a gradual decline by the age of 10. Detection of inhibin indicates the presence and functional ability of testicular tissues, and is used to determine the sex in suspicious situations and pathologies in the development of the gonads.

Analysis of this hormone allows us to distinguish between anorexia (congenital absence of testicles) and cryptorchidism (testicles are not present in the testis) in order to timely prescribe the necessary treatment.

When should we take the test?

Inhibin A – Ovarian reserve marker (along with FSH and AMH). A marker of granulosa cell ovarian cancer.

In women:

  • Diagnosis of pubertal disorders;
  • Complex examination of women to determine the causes of infertility, menstrual disorders, premature ovarian failure and to assess ovarian reserve;
  • Determining the time of transition to ART in the treatment of infertility.
  • Predicting the effectiveness of infertility treatment with various ART methods;
  • Predicting the effectiveness of ovarian stimulation in IVF cycles;
  • Diagnosis of mucinous type of ovarian granulocyte and epithelial tumors, monitoring the effectiveness of treatment, evaluation of recurrence and metastases. (With CA-125).

In men:

  • Diagnosis of pubertal disorders;
  • Complex examination of infertility, disorders of spermatogenesis.

Testing is preferred Fasting.

women: The patient should indicate the date of the last menstrual period. It is best to determine on the 3rd day of the menstrual cycle (when the peak level is observed).

Possible interpretation of the results

Increased levels of inhibin A:

  • Polycystic ovary syndrome;
  • Granular-cell ovarian cancer;
  • Mucinous type of ovarian epithelial cancer;
  • Antiandrogen therapy (in men).

A decrease in the level of inhibin A:

women:

  • Decreased age-related follicular reserve of the ovary;
  • During menopause;
  • Premature ovarian failure;
  • Surgical menopause;
  • Antitumor chemotherapy.

men:

  • Disruption of spermatogenesis, especially in its early stages;
  • Hyper- and hypogonadotropic hypogonadism.

Additional information

Testing process

Purchase a test Submission of material

Purchase a test

Submission of material

Results Online Consult a doctor

Results Online

Consult a doctor

Laboratories
Call Now Button